NCT04747808: A trial that was reported late by MediPrint Ophthalmics, Inc.
This trial has reported, although it was 58 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04747808 |
|---|---|
| Title | A Phase 2a Study of Safety, Tolerability, and Efficacy of Drug-Delivering Contact Lens LL-BMT1 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 8, 2021 |
| Completion date | Feb. 16, 2021 |
| Required reporting date | Feb. 16, 2022, midnight |
| Actual reporting date | April 15, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 58 |